3

PRIMARY DOCUMENT

Company: INOVIO PHARMACEUTICALS, INC.
Filed: February 3, 2011
Period of Report: January 24, 2011
Accession Number: 0001044321-11-000032

View Document ↗ View on SEC.gov ↗